A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

NCT02160132 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Glomerulonephritis, IGA
Peripapillary Crescent
Necrosis
Steroid Nephropathy

Interventions

DRUG: Methylprednisolone(intravenously in the 1st-2nd-3rd month )
DRUG: Methylprednisolone(intravenously in the 1st-3rd-5th month)

Sponsor

Sun Yat-sen University